Juvenile Idiopathic Arthritis (JIA)

At Nemours, we promise to do whatever it takes to treat children as we would our own. When your child comes to Nemours, we know you’re placing your trust in us. This trust and our dedication to improving the health of your child is what inspires us to provide exceptional care and the most satisfying experience possible.


Research Into the Causes of Juvenile Idiopathic Arthritis (JIA)

Nemours pediatric rheumatologists and research scientists in the Delaware Valley and Florida are among the nation’s leading JIA investigators.

We’re looking into some of the genetic markers that make an individual more likely to get JIA as well as other markers that could help determine how effectively various treatments might work to reduce the symptoms of the condition in certain people. We’ve also published studies that help doctors decide which does of some medications work most effectively with the fewest side effects.

With all this research activity focused on JIA diagnosis and treatment, you may want to look into the possibility that your child may qualify to participate in a clinical trial. A clinical trial is a study that evaluates new medicines, new devices, new treatments, or new applications for old treatments.

Clinical trials are safe and supervised by a qualified physician, under strict guidance of the Food and Drug Administration (FDA). Patient safety is extremely important to the FDA, to those conducting the studies, and to everyone at Nemours. In a clinical trial, children participating in the study are monitored closely – and families may refuse any aspect of the study treatment or completely discontinue their child’s participation in the clinical trial at any time.

For information about current clinical trials in:
Wilmington, DE: (302) 651-6800
Orlando, FL: (407) 650-7150

Is a clinical trial right for your child?